ARCHIVES

How ImClone’s “Hot” New Drug Got Cold Shoulder From FDA

This article is from The Cancer Letter archive.

Vol. 28 No. | March 8, 2002

Download PDF Visit The Full Archive

Related Articles

NCI News Roundup: clinical Trials Initiatives Explained in Lectures Available Online

June 11, 1999

Next Bypass Budget: Slim, Trim, Modest

September 15, 1995

Cytyc Buys Pro-Duct Health, Ductal Lavage Device Maker. TAP To Pay $875 Million To Settle Federal Civil Suit.

October 26, 2001

Fisher, interim NSABP Leadership Enter Third Day Of Negotiations To Settle Suit, Aver Court Battle

September 30, 1994

NCAB TO Reconsider Decision Not To Fund Diet Fit Trial

October 20, 1989

NCI Planning To Switch Drug Development Emphasis From Compound To Human Cancer Oriented Strategy

October 26, 1984